Eric M Schreier, DO | |
3909 New Vision Dr, Suite 1, Fort Wayne, IN 46845-1725 | |
(260) 469-6602 | |
(260) 458-5664 |
Full Name | Eric M Schreier |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 3909 New Vision Dr, Fort Wayne, Indiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386641587 | NPI | - | NPPES |
2037450 | Medicaid | OH | |
250007771 | Other | IN | RR MEDICARE |
P00867166 | Other | IN | MEDICARE RR |
200127140 | Medicaid | IN | |
4819336 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 02001837A (Indiana) | Primary |
Entity Name | Parkview Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it is planning to expand the development of Gencaro, its lead cardiovascular drug candidate, to atrial fibrillation, a disease that affects more than 2.4 million patients in the United States.
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body. Tiny capsules, called nanoparticles, are now being used to transport chemotherapy medicine through the bloodstream, to the doorstep of cancerous tumors.
In the novel À la recherche du temps perdu (translated into English as Remembrance of Things Past), Marcel Proust makes a compelling case that our identities and decisions are shaped in profound and ongoing ways by our memories.
Members of the European Parliament Heart Group (MEP HG) meet today (9 December), in Brussels, with the Cardiology profession and representatives of national Heart Foundations to evaluate the achievements at EU level in combating Cardiovascular Disease (CVD), and to reveal the need for further action.
A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute's Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Eric M Schreier, DO 1234 E Dupont Rd, Suite 3, Fort Wayne, IN 46825-1545 Ph: (260) 373-9700 | Eric M Schreier, DO 3909 New Vision Dr, Suite 1, Fort Wayne, IN 46845-1725 Ph: (260) 469-6602 |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it is planning to expand the development of Gencaro, its lead cardiovascular drug candidate, to atrial fibrillation, a disease that affects more than 2.4 million patients in the United States.
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body. Tiny capsules, called nanoparticles, are now being used to transport chemotherapy medicine through the bloodstream, to the doorstep of cancerous tumors.
In the novel À la recherche du temps perdu (translated into English as Remembrance of Things Past), Marcel Proust makes a compelling case that our identities and decisions are shaped in profound and ongoing ways by our memories.
Members of the European Parliament Heart Group (MEP HG) meet today (9 December), in Brussels, with the Cardiology profession and representatives of national Heart Foundations to evaluate the achievements at EU level in combating Cardiovascular Disease (CVD), and to reveal the need for further action.
A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute's Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.
› Verified 1 days ago
David S Stensland, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7201 Engle Rd, Fort Wayne, IN 46804 Phone: 260-432-1800 Fax: 260-432-1804 | |
Mr. Jeremy R. Gall, ATC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7601 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-2620 | |
Elijah Klepper, PT, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 11143 Parkview Plaza Dr Ste 100, Fort Wayne, IN 46845 Phone: 260-266-7400 Fax: 260-266-7439 | |
Sayed E. Wahezi, MD Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 3898 New Vision Dr, Suite B, Fort Wayne, IN 46845 Phone: 260-459-7313 Fax: 260-436-0628 | |
Elisha Lynn Hardesty, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 11143 Parkview Plaza Dr Ste 100, Fort Wayne, IN 46845 Phone: 260-266-7400 Fax: 260-266-7439 | |
Delaney Faith Werling, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2200 Randallia Dr, Fort Wayne, IN 46805 Phone: 260-373-3202 | |
Kayla Sue Ann Brumbaugh, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7125 Hanna St, Fort Wayne, IN 46816 Phone: 260-249-9818 |